Long-term treatment with procaine (Gerovital H3) in albino rats

clinical paper · 1965

type:clinical paper

year:1965

citation:Aslan A, Vrabiescu A, Domilescu C, Campeanu L, et al. 'Long-term treatment with procaine (Gerovital H3) in albino rats.' *Journal of Gerontology* 1965 Jan;20:1-8. PMID 14246524. doi:10.1093/geronj/20.1.1.

LINK

https://pubmed.ncbi.nlm.nih.gov/14246524/

SUMMARY

Ana Aslan's own animal study reporting that long-term procaine (Gerovital H3) treatment extended the lifespan of albino rats, the experimental basis she advanced for the anti-aging claim. Cited here as the primary statement of the longevity claim by its originator, not as independent confirmation; the systemic human evidence was later found wanting by Ostfeld et al (1977). Citation metadata (authors, journal, year, volume, pages, PMID, DOI) copied from the NCBI PubMed record and Crossref on 2026-06-03 (esummary: 'ASLAN A, VRABIESCU A, DOMILESCU C, CAMPEANU L', J Gerontol 20:1-8, 1965 Jan, PMID 14246524; DOI 10.1093/geronj/20.1.1).

NOTES

This 1965 Journal of Gerontology paper is Aslan’s own report that long-term procaine (Gerovital H3) prolonged the life of albino rats. It is the experimental claim she carried into the promotion of Gerovital for human aging. The bundle cites it as the originator’s statement of the longevity claim, classified as untested-to-refuted at the human level: the broad human evidence was reviewed and rejected by Ostfeld, Smith, and Stotsky in 1977.